Worldwide Experience of Metformin as an Effective Glucose-lowering Agent: A Meta-analysis

This publication has 24 references indexed in Scilit:

• The American Diabetes Association Annual Meeting, 1994: Treatment Issues fer NIDPM
  Diabetes Care, 1994
• Metformin—An update
  General Pharmacology: The Vascular System, 1993
• Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groups
  Diabetes Care, 1993
• Is It Time To Introduce Metformin in the U.S.?
  Diabetes Care, 1993
• Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles
  European Journal of Clinical Pharmacology, 1991
• Comparison of Tolbutamide and Metformin in Elderly Diabetic Patients
  Diabetic Medicine, 1990
• The Effect of Glibenclamide and Metformin on Serum Lipoproteins in Type 2 Diabetes
  Diabetic Medicine, 1988
• U.K. Prospective Diabetes Study: II. Reduction in HbA1c with Basal Insulin Supplement, Sulfonylurea, or Biguanide Therapy in Maturity-onset Diabetes
  Diabetes, 1985
• Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet.
  BMJ, 1977
• COMPARISON OF CHLORPROPAMIDE AND METFORMIN TREATMENT ON WEIGHT AND BLOOD-GLUCOSE RESPONSE OF UNCONTROLLED OBESE DIABETICS
  The Lancet, 1968